Hao Xue

ORCID: 0000-0001-7478-8898
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MicroRNA in disease regulation
  • Extracellular vesicles in disease
  • Cancer-related molecular mechanisms research
  • Circular RNAs in diseases
  • Glioma Diagnosis and Treatment
  • RNA modifications and cancer
  • Autophagy in Disease and Therapy
  • Immune cells in cancer
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis
  • Radiomics and Machine Learning in Medical Imaging
  • Intracerebral and Subarachnoid Hemorrhage Research
  • RNA Research and Splicing
  • Sulfur Compounds in Biology
  • Nanoplatforms for cancer theranostics
  • Hepatitis C virus research
  • Nuclear Receptors and Signaling
  • Cardiovascular Disease and Adiposity
  • Cellular Mechanics and Interactions
  • Endoplasmic Reticulum Stress and Disease
  • Cancer Research and Treatments
  • Intracranial Aneurysms: Treatment and Complications
  • Signaling Pathways in Disease
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Advanced Electron Microscopy Techniques and Applications

Qilu Hospital of Shandong University
2015-2025

Shanghai Center for Brain Science and Brain-Inspired Technology
2020-2025

Wuhan University
2025

Renmin Hospital of Wuhan University
2025

Central Hospital of Zibo
2025

Sichuan Agricultural University
2024

Shandong University
2009-2024

Baogang Group (China)
2023

Chinese People's Liberation Army
2012-2022

Stanford University
2022

Gliomas are the most common malignant primary brain tumours with a highly immunosuppressive tumour microenvironment (TME) and poor prognosis. Circular RNAs (circRNA), newly found type of endogenous noncoding RNA, characterized by high stability, abundance, conservation, have been shown to play an important role in pathophysiological processes TME remodelling various tumours.CircRNA sequencing analysis was performed explore circRNA expression profiles normal glioma tissues. The biological...

10.1186/s12943-021-01485-6 article EN cc-by Molecular Cancer 2022-01-14

Abstract Exosomes participate in intercellular communication and glioma microenvironment modulation, but the exact mechanisms by which glioma-derived exosomes (GDEs) promote generation of immunosuppressive are still unclear. Here, we investigated effects GDEs on autophagy, polarization tumor-associated macrophages (TAMs), progression. Compared with normoxic (N-GDEs), hypoxic (H-GDEs) markedly facilitated autophagy M2-like macrophage polarization, subsequently promoted proliferation migration...

10.1038/s41419-021-03664-1 article EN cc-by Cell Death and Disease 2021-04-07

Glioblastoma (GBM) is one of the most fatal central nervous system tumors and lacks effective or sufficient therapies. Ferroptosis a newly discovered method programmed cell death opens new direction for GBM treatment. However, poor blood-brain barrier (BBB) penetration, reduced tumor targeting ability, potential compensatory mechanisms hinder effectiveness ferroptosis agents during Here, novel composite therapeutic platform combining magnetic features drug delivery properties nanoparticles...

10.1002/advs.202105451 article EN Advanced Science 2022-05-04

Abstract Exosomes can selectively secrete harmful metabolic substances from cells to maintain cellular homeostasis, and complex crosstalk occurs between exosomes tumor-associated macrophages (TAMs) in the glioma immune microenvironment. However, precise mechanisms by which these exosome-encapsulated cargos create an immunosuppressive microenvironment remain unclear. Herein, we investigated effect of glioma-derived (GDEs) on macrophage polarization progression. We performed sequencing...

10.1038/s41388-022-02457-w article EN cc-by Oncogene 2022-09-09

Myeloid‐derived suppressor cells (MDSCs) play a pivotal role in mediating the formation of an immunosuppressive environment and assisting tumors evading host immune response. However, mechanism through which manipulate differentiation function MDSCs remains unclear. Here, we report that hypoxia‐induced glioma can stimulate functional by transferring exosomal miR‐29a miR‐92a to MDSCs. Our results showed glioma‐derived exosomes (GEXs) enhance both vitro vivo , GEXs (H‐GEXs) demonstrated...

10.1002/ijc.32052 article EN International Journal of Cancer 2018-12-11

Hypoxia induces protective autophagy in glioblastoma cells and new therapeutic avenues that target this process may improve the outcome for patients. Recent studies have suggested autophagic is upregulated glioblastomas response to extensive hypoxia. also upregulation of a specific set proteins microRNAs (miRNAs) variety cell types. IL6 (interleukin 6), an inflammatory autocrine paracrine cytokine overexpressed glioblastoma, has been reported be biomarker poor prognosis because its...

10.1080/15548627.2016.1178446 article EN cc-by-nc Autophagy 2016-05-10

Glioma is a heterogeneous cellular environment in which immune cells play critical roles tumor progression. Myeloid-derived suppressor (MDSCs) contribute to the formation of immunosuppressive microenvironment glioma; however, how glioma interact with MDSCs and this interaction affects function other are unclear. can systemically communicate via secretion exosomes, contain microRNAs (miRNAs). Leveraging miRNA sequencing we identified enrichment miR-1246 glioma-derived exosomes isolated from...

10.1016/j.ymthe.2021.06.023 article EN cc-by-nc-nd Molecular Therapy 2021-07-02

Abstract Patients with subarachnoid hemorrhage (SAH) often suffer from cognitive function impairments even when they have received proper treatment, such as the clipping or coiling of aneurysms, and this causes problems returning to work burdens family. Increasing attention has been paid mesenchymal stem cell (MSC)-derived extracellular vesicle (MSC-EV) promising therapeutic vesicles for stroke management. In study, we explored potential role MSC-EV in a rat model SAH. We observed that...

10.1038/s41419-020-2530-0 article EN cc-by Cell Death and Disease 2020-05-13

Proneural-to-mesenchymal transition (PMT) is a common process in glioblastoma (GBM) progression that leads to increased radiotherapy resistance. However, the mechanism underlying PMT poorly understood. Here, we found tumor-associated macrophages triggered glioma stem cells (GSC) via small extracellular vesicles (sEV). sEVs from monocyte-derived transferred miR-27a-3p, miR-22-3p, and miR-221-3p GSCs, these miRNAs promoted several mesenchymal phenotypes proneural (PN) GSCs by simultaneously...

10.1158/2326-6066.cir-19-0759 article EN Cancer Immunology Research 2020-04-29

Abstract Clear evidence shows that tumors could secrete microRNAs (miRNAs) via exosomes to modulate the tumor microenvironment (TME). However, mechanisms sorting specific miRNAs into are still unclear. In order study biological function and characterization of exosomal miRNAs, we performed whole-transcriptome sequencing in 59 patients’ whole-course cerebrospinal fluid (CSF) small extracellular vesicles (sEV) matched glioma tissue samples. The results demonstrate be divided exosome-enriched...

10.1038/s41419-022-04872-z article EN cc-by Cell Death and Disease 2022-05-02

Resistance to temozolomide (TMZ) is a major obstacle preventing glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) play variety of roles in GBM, the lncRNAs that regulate TMZ resistance have not yet been clearly elucidated. This study aims identify may affect treatment sensitivity and explore novel therapeutic strategies overcome GBM.LncRNAs associated with were identified using Cancer Cell Line Encyclopedia (CCLE) Genomics Drug Sensitivity (GDSC) datasets....

10.1186/s13046-022-02431-0 article EN cc-by Journal of Experimental & Clinical Cancer Research 2022-07-15

Abstract Glioma is the most common malignant tumor of central nervous system in adults. The microenvironment (TME) related to poor prognosis glioma patients. cells could sort miRNA into exosomes modify TME. And hypoxia played an important role this sorting process, but mechanism not clear yet. Our study was find miRNAs sorted and reveal process. Sequencing analysis patients cerebrospinal fluid (CSF) tissue showed that miR-204-3p tends be exosomes. suppressed proliferation through...

10.1038/s41419-023-05663-w article EN cc-by Cell Death and Disease 2023-02-21

Background: Glioma stem cells (GSCs) are a key factor in glioblastoma (GBM) development and treatment resistance.GSCs can be divided into the mesenchymal (MES) proneural (PN) subtypes, these two subtypes of GSCs undergo interconversion under certain conditions.MES have higher malignancy radioresistance closely associated with an immunosuppressive microenvironment.Long noncoding RNAs (lncRNAs) play broad role GBM, while subtype remains unknown.Methods: We performed RNA sequencing to explore...

10.7150/thno.82590 article EN cc-by Theranostics 2023-01-01

Abstract Background Cullin-7 (CUL7) is a member of the DOC domain-containing cullin family and involved in regulation cell transformation. However, clinical significance, potential mechanism upstream regulators CUL7 malignant gliomas remain to be determined. Methods Expression level data information were obtained via Cancer Genome Atlas (TCGA) database, Chinese Glioma (CGGA) immunohistochemistry (IHC) western blot analysis. Gene set enrichment analysis (GSEA) was used explore molecular...

10.1186/s13046-020-01553-7 article EN cc-by Journal of Experimental & Clinical Cancer Research 2020-04-06

Vasculogenic mimicry (VM), the formation of an alternative microvascular circulation independent VEGF-driven angiogenesis, is reluctant to anti-angiogenesis therapy for glioma patients. However, treatments targeting VM are lacking due poor understanding molecular mechanism involved in formation. By analysing TCGA database, microRNA-29a-3p (miR-29a-3p) was found be highly expressed normal brain tissue compared with glioma. An vitro study revealed inhibitory role miR-29a-3p cell migration and...

10.18632/aging.202424 article EN cc-by Aging 2021-02-01

Subarachnoid hemorrhage (SAH) is an acute and severe disease with high disability mortality. Inflammatory reactions have been proven to occur throughout SAH. Extracellular vesicles derived from mesenchymal stem cells (MSCs-EVs) shown broad potential for the treatment of brain dysfunction neuroprotective effects through neurogenesis angiogenesis after stroke. However, mechanisms EVs in neuroinflammation during phase SAH are not well known. Our present study was designed investigate MSCs-EVs...

10.1016/j.biopha.2020.111048 article EN Biomedicine & Pharmacotherapy 2020-11-28

Abstract This study was to develop a radiomics nomogram mainly using wavelet features for identifying malignant and benign early-stage lung nodules high-risk screening. A total of 116 patients with solitary pulmonary (SPNs) (≤ 3 cm) were divided into training set (N = 70) validation 46). Radiomics extracted from plain LDCT images each patient. signature then constructed the LASSO set. Combined independent risk factors, built multivariate logistic regression model. signature, consisting one...

10.1038/s41598-021-01470-5 article EN cc-by Scientific Reports 2021-11-16

Background Glioblastoma (GBM), one of the most aggressive tumors brain, has no effective or sufficient therapies. Identifying robust biomarkers for response to immune checkpoint blockade (ICB) therapy, a promising treatment option GBM patients, is urgently needed. Methods We comprehensively evaluated lncRNA m 6 A modification patterns in A-sequencing (m A-seq) data tissues and systematically investigated stromal regulators these A-regulated lncRNAs. used single-sample gene-set enrichment...

10.3389/fimmu.2021.653711 article EN cc-by Frontiers in Immunology 2021-07-20

As one of the most common post-transcriptional modifications mRNAs and noncoding RNAs, N6-methyladenosine (m6A) modification regulates almost every aspect RNA metabolism. Evidence indicates that dysregulation m6A associated proteins contributes to glioblastoma (GBM) progression. However, function fat mass obesity-associated protein (FTO), an demethylase, has not been systematically comprehensively explored in GBM. Here, we found decreased FTO expression clinical specimens correlated with...

10.1016/j.omtn.2021.12.035 article EN cc-by-nc-nd Molecular Therapy — Nucleic Acids 2022-01-01
Coming Soon ...